Furthermore, FASN mediates the epithelial-mesenchymal transition (EMT) of breast cancer cells as its inhibition with cerulenin increases and decreases respectively the expression of E-cadherin and vimentin, and inhibits cell migration [45]. This evidence concerns the gene FASN and breast carcinoma.